ASH Daily News 26 January 2018
- Yorkshire: Taxi driver fined for smoking in his cab
- Cambridge University Conservative Association to host tobacco funded lobbyists
- USA: Panel rejects Philip Morris claim that IQOS cuts disease risk
- USA: Universities refuse money from tobacco industry funded foundation
- Singapore: Alternative nicotine and tobacco products to be banned
Link of the Week
- British Thoracic Society Smoking Cessation Quality Improvement Tool
Yorkshire: Taxi driver fined for smoking in his cab
A taxi driver has pleaded guilty to two counts of smoking inside his vehicle and fined a total of £165 by Skipton Magistrates Court. Taxis are covered by smokefree legislation which came into force in July 2007.
Source: Telegraph & Argus, 25 January
Cambridge University Conservative Association to host tobacco funded lobbyists
Cambridge University Conservative Association (CUCA) is set to host tobacco industry funded lobby group FOREST. FOREST, short for Freedom Organisation for the Right to Enjoy Smoking Tobacco, receives 96% of its funding from the UK tobacco industry, and campaigns against what it deems the ‘denormalisation’ of tobacco.
Student Union Ethical Affairs Officer, Dylan Amin, told Varsity: “While there is nothing we can do to prevent this association between CUCA and FOREST, we are surprised to hear of its existence. The arguments for tobacco control are coherent, powerful and backed up intensely by research … we condemn FOREST’s work, making us thoroughly disappointed by this event.”
Source: Varsity, 26 January 2018
USA: Panel rejects Philip Morris claim that IQOS cuts disease risk
Philip Morris International should not be allowed to claim that its heat not burn tobacco product IQOS can reduce the risk of tobacco related disease compared to cigarettes, an advisory panel to the US Food and Drug Administration (FDA) has concluded.
The panel did conclude that Philip Morris had shown IQOS exposes users to lower levels of harmful chemicals but not that lowering this exposure can be linked to a measureable reduction in risk of disease or death. Philip Morris needs to show both in order to make modified risk claims.
The FDA is not bound by the decision of its advisory panel, but will make a decision within the next few months on whether IQOS can be sold in the US and separately on whether it can make modified risk claims compared to cigarettes.
Shares in the company were down 2.8% Thursday afternoon having fallen by as much as 6.8%.
The Financial Times: Philip Morris, Altria hit by FDA advisory panel ruling on IQOS devices
Reuters: U.S. panel deals blow to Philip Morris tobacco device
Source: The Guardian, 25 January 2018
USA: Universities refuse money from tobacco industry funded foundation
Public Health schools at 17 universities across the US and Canada have said they will refuse funds from the tobacco industry funded Foundation for a Smoke-Free World.
The Foundation was established in September by tobacco company Philip Morris International which has committed $1 billion in funding for the project. The reported aim is to end smoking worldwide and support research to achieve that goal, the Foundation says it will be independent of PMI.
However, the universities have said the Foundation is too closely linked to the industry: “The idea of taking money that’s from the tobacco industry is just antithetical to everything we do,” said Karen Emmons, dean for academic affairs at Harvard’s public health school. “Philip Morris in particular has focused very hard to undermine the strategies that we know will reduce smoking rates.”
A statement signed by the 17 deans says that if Philip Morris wants to end smoking, it should stop selling and advertising cigarettes.
Source: Medical Xpress, 25 January 2018
Singapore: Alternative nicotine and tobacco products to be banned
From 1st February 2018 buying, using or possessing alternative tobacco and nicotine devices is going to be banned. The law will cover alternative tobacco products such as shisha and smokeless tobacco as well as nicotine containing products such as e-cigarettes. Currently the import, sale and distribution of such products is prohibited.
The changes come under amendments to the Tobacco (Control of Advertisement and Sale) Act passed in November 2017. Alongside these changes the legal age for the purchase, use, possession, sale and supply of tobacco products will rise from 18 to 21 by 2021.
Source: The Straits Times, 26 January 2018
Link of the Week
British Thoracic Society Smoking Cessation Quality Improvement Tool
The British Thoracic Society has launched a Quality Improvement Tool for Smoking Cessation to support hospitals in improving their support for smokers.
The tool contains a range of educational materials and examples for how to tackle the three key areas for improvement: referrals to specialist stop smoking services, prescriptions of nicotine replacement therapies and staff training.
Source: British Thoracic Society, January 2018